Atlas Trials

A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)

Clinical trial NCT04083820 · COMPLETED

Trial details

NCT number
NCT04083820
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes Mellitus, Type 2
Start date
2019-09-16
Primary completion
2021-09-27
Enrollment
521

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.